Biken Techno Corporation (9791) AI Stock Analysis

• Market Cap: ¥8.57B
• Dividend Yield: 2.46%
• Average Volume (3M): 7.76K
• Price to Earnings (P/E): 7.7
• Beta (1Y): 0.54
• Revenue Growth: -7.83%
• EPS Growth: -13.14%
• Country: JP
• Employees: 2,517
• Sector: Industrials
• Sector Strength: 79
• Industry: Specialty Business Services
• EPS (TTM): 55.01
• Shares Outstanding: 7,718,722
• 10 Day Avg. Volume: 7,840
• 30 Day Avg. Volume: 7,763
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥1,050.00
• Price Target Upside: -7.57% Downside
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 66 Neutral
• Price Target: ¥1,050.00 ▼(-7.57% Downside)

The stock is primarily influenced by its financial performance and valuation. While it has a strong equity position and appears undervalued, the revenue volatility and cash flow issues are significant concerns. Technical signals add further caution with mixed indicators.

Biken Techno Corporation Business Overview & Revenue Model

Company Description

Biken Techno Corporation (9791) is a company engaged in the manufacturing and distribution of pharmaceutical products. The company primarily focuses on the production of vaccines, diagnostics, and other related healthcare products. Biken Techno Corporation operates within the healthcare and biotechnology sectors, aiming to develop innovative solutions to improve public health and disease prevention.

How the Company Makes Money

Biken Techno Corporation makes money through the sale of its pharmaceutical products, including vaccines and diagnostics, to healthcare providers, government agencies, and distributors. The company generates revenue by developing and commercializing vaccines that address various infectious diseases. Key revenue streams include product sales, licensing agreements, and potential collaborations with research institutions or pharmaceutical companies. The company's earnings could also be influenced by government contracts or public health initiatives that require large-scale vaccine production and distribution.

Biken Techno Corporation Financial Statement Overview

Summary

Biken Techno Corporation maintains a solid operational base with stable margins and a strong equity ratio. However, revenue volatility and cash flow challenges present risks to financial stability.

Income Statement

The company exhibits a stable gross profit margin, showcasing operational efficiency. However, the net profit margin has been fluctuating, indicating challenges in managing expenses. Revenue growth has been inconsistent with recent declines, affecting overall performance. Despite these challenges, the EBIT and EBITDA margins remain relatively stable, suggesting underlying operational strengths.

Balance Sheet

The balance sheet reflects a strong equity position with a favorable equity ratio, indicating financial stability. The debt-to-equity ratio is manageable, suggesting the company can sustain its leverage. However, return on equity has been inconsistent, reflecting challenges in generating returns from equity investments.

Cash Flow

The company's cash flow situation is concerning, with negative free cash flow in recent years. Operating cash flow has also been inconsistent, affecting liquidity. The free cash flow to net income ratio indicates challenges in converting earnings into free cash flow, posing a risk to financial flexibility.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	34.67B	34.67B	38.37B	34.69B	31.39B	34.60B
Gross Profit	7.43B	7.19B	7.82B	7.38B	6.53B	6.24B
EBITDA	2.19B	2.19B	3.16B	3.10B	2.63B	2.12B
Net Income	978.61M	979.06M	1.31B	1.67B	1.36B	1.05B
Balance Sheet
Total Assets	40.35B	40.35B	41.18B	39.24B	39.74B	35.38B
Cash, Cash Equivalents and Short-Term Investments	9.56B	9.56B	11.91B	7.82B	7.17B	6.69B
Total Debt	10.81B	10.81B	11.82B	12.18B	13.92B	11.64B
Total Liabilities	18.70B	18.70B	20.38B	19.57B	21.45B	18.17B
Stockholders Equity	21.65B	21.65B	20.81B	19.67B	18.29B	17.21B
Cash Flow
Free Cash Flow	0.00	-2.54B	1.06B	2.23B	-782.15M	5.36B
Operating Cash Flow	0.00	-2.15B	3.51B	2.53B	-488.50M	5.48B
Investing Cash Flow	0.00	1.90B	82.89M	60.71M	-987.79M	-1.37B
Financing Cash Flow	0.00	-1.21B	-604.99M	-1.96B	1.95B	-3.37B

Biken Techno Corporation Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 1136.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Negative
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:9791, the sentiment is Positive. The current price of 1136 is above the 20-day moving average (MA) of 1078.00, above the 50-day MA of 1018.06, and above the 200-day MA of 954.98, indicating a bullish trend. The MACD of 39.52 indicates Negative momentum. The RSI at 73.06 is Negative, neither overbought nor oversold. The STOCH value of 66.76 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:9791.

Biken Techno Corporation Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
9780	81 Outperform	¥8.42B	9.35		2.74%	5.72%	5.77%
3551	80 Outperform	¥8.02B	6.09		3.17%	4.18%	23.01%
6044	72 Outperform	¥11.62B	16.54		1.24%	6.20%	46.97%
7371	71 Outperform	¥8.76B	25.18		1.83%	-1.60%	40.42%
7049	69 Neutral	¥7.24B	17.85		―	7.94%	364.35%
9791	66 Neutral	¥8.57B	7.72		2.46%	-7.83%	-13.14%
Sector *	64 Neutral	$10.86B	16.10	7.81%	1.99%	2.67%	-15.47%